Validation of the fatigue severity scale in a Swiss cohort
- PMID: 19014080
- PMCID: PMC2579971
- DOI: 10.1093/sleep/31.11.1601
Validation of the fatigue severity scale in a Swiss cohort
Abstract
Background: Fatigue is highly prevalent and has a negative impact on quality of life and performance in a variety of disorders. The 9-item Fatigue Severity Scale (FSS) is one of the most commonly used self-report questionnaires to measure fatigue, but has only been validated in small sample-sized studies and in single disorders.
Objective: To validate the FSS in healthy subjects and different disorders known to be commonly associated with fatigue.
Material and methods: The FSS was administered to 454 healthy subjects, 188 patients with multiple sclerosis (MS), 235 patients with recent ischemic stroke, and 429 patients with sleep-wake disorders including narcolepsy with cataplexy (n=22), restless legs syndrome (RLS) (n=79), sleep apnea (n=108), insomnia (n=62), parasomnia (n=25), excessive daytime sleepiness/hypersomnia of other origin (n=84, and other sleep-wake disorders (n=49.
Results: FSS scores were 4.66 +/- 1.64 (mean +/- SD) in patients with MS, 3.90 +/- 1.85 in patients after ischemic stroke, and 4.34 +/- 1.64 in patients with sleep-wake disorders. Compared to patients, values were significantly lower in healthy subjects (3.00 +/- 1.08, P < 0.01). Scores did not correlate with gender, age, or education. Item analysis showed an excellent internal consistency and reliability (Cronbach alpha = 0.93). Test-retest variability was assessed in 104 healthy subjects, showing stable values over time (2.94 +/- 0.90 vs. 2.90 +/- 0.74; P = 0.27).
Conclusions: This first validation of a fatigue scale in a large sample size demonstrates that the FSS is a simple and reliable instrument to assess and quantify fatigue for clinical and research purposes.
Figures
Similar articles
-
Sleep disorders in patients with multiple sclerosis.J Clin Sleep Med. 2015 Apr 15;11(5):553-7. doi: 10.5664/jcsm.4702. J Clin Sleep Med. 2015. PMID: 25700869 Free PMC article.
-
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.Neurol Neurochir Pol. 2012 Jul-Aug;46(4):309-17. doi: 10.5114/ninp.2012.30261. Neurol Neurochir Pol. 2012. PMID: 23023429
-
The underdiagnosis of sleep disorders in patients with multiple sclerosis.J Clin Sleep Med. 2014 Sep 15;10(9):1025-31. doi: 10.5664/jcsm.4044. J Clin Sleep Med. 2014. PMID: 25142763 Free PMC article.
-
Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients.Braz J Med Biol Res. 2008 Oct;41(10):932-7. doi: 10.1590/s0100-879x2008001000017. Braz J Med Biol Res. 2008. PMID: 19030714
-
Excessive daytime sleepiness: considerations for the psychiatrist.Psychiatr Clin North Am. 2006 Dec;29(4):921-45; abstract viii. doi: 10.1016/j.psc.2006.09.004. Psychiatr Clin North Am. 2006. PMID: 17118275 Review.
Cited by
-
Lived Experiences of Sexuality and Sexual Functioning in Males with SCI: A Mixed-Methods Study.Top Spinal Cord Inj Rehabil. 2024 Spring;30(2):37-53. doi: 10.46292/sci23-00082. Epub 2024 May 23. Top Spinal Cord Inj Rehabil. 2024. PMID: 38799605
-
The Effect of 14-Day Consumption of Hydrogen-Rich Water Alleviates Fatigue but Does Not Ameliorate Dyspnea in Long-COVID Patients: A Pilot, Single-Blind, and Randomized, Controlled Trial.Nutrients. 2024 May 19;16(10):1529. doi: 10.3390/nu16101529. Nutrients. 2024. PMID: 38794767 Free PMC article. Clinical Trial.
-
Assessment of Sleep Disorders in Patients with CVID.J Clin Immunol. 2024 Apr 27;44(5):109. doi: 10.1007/s10875-024-01711-y. J Clin Immunol. 2024. PMID: 38676767
-
Exploring the Mediating Role of Sleep Deficit-Related Functional Status in Subacute Stroke Survivors.Medicina (Kaunas). 2024 Feb 29;60(3):422. doi: 10.3390/medicina60030422. Medicina (Kaunas). 2024. PMID: 38541148 Free PMC article.
-
Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1.Orphanet J Rare Dis. 2024 Mar 7;19(1):103. doi: 10.1186/s13023-024-03114-z. Orphanet J Rare Dis. 2024. PMID: 38454488 Free PMC article.
References
-
- Chaudhuri A. Fatigue in neurological disorders. Lancet. 2004;363:978–88. - PubMed
-
- Krupp LB, et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology. 1995;45:1956–61. - PubMed
-
- Branas P, et al. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess. 2000;4:1–61. - PubMed
-
- Zifko UA. Management of fatigue in patients with multiple sclerosis. Drugs. 2004;64:1295–1304. - PubMed
-
- Lichstein KL. Fatigue and sleep disorders. Behav Res Ther. 1997;35:733–40. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical